IBIO, INC. Financing Cash Flow
IBIO, INC. (IBIO) reported Financing Cash Flow of $103.05 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-28.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-28
- IBIO, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $19.40M, a 137.21% increase year-over-year.
- IBIO, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $28.15M, a 2548.54% increase year-over-year.
- IBIO, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $8.79M.
- IBIO, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $46.70M.
- IBIO, INC. net cash provided by (used in) financing activities for fiscal 2026 was $103.05M, a 1054.08% increase from fiscal 2025.
- IBIO, INC. net cash provided by (used in) financing activities for fiscal 2025 was $8.93M, a 63.55% decline from fiscal 2024.
- IBIO, INC. net cash provided by (used in) financing activities for fiscal 2024 was $24.49M, a 964.49% increase from fiscal 2023.
- IBIO, INC. net cash provided by (used in) financing activities for fiscal 2023 was $2.30M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $19.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-28 | $47.56M derived: sum of 2 quarters · filed 2026-08-28 | $56.34M derived: sum of 3 quarters · filed 2026-08-28 | $103.05M 10-K · filed 2026-08-28 | |
| 2026-03-31 | $28.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-12 | $36.94M derived: sum of 2 quarters · filed 2026-05-12 | $83.64M 10-Q · filed 2026-05-12 | $91.82M derived: sum of 4 quarters · filed 2026-08-28 | |
| 2025-12-31 | $8.79M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2026-02-10 | $55.49M 10-Q · filed 2026-02-10 | $63.67M derived: sum of 3 quarters · filed 2026-08-28 | $64.73M derived: sum of 4 quarters · filed 2026-08-28 | |
| 2025-09-30 | $46.70M 10-Q/A · filed 2025-11-17 | $54.88M derived: sum of 2 quarters · filed 2026-08-28 | $55.95M derived: sum of 3 quarters · filed 2026-08-28 | $55.80M derived: sum of 4 quarters · filed 2026-08-28 | |
| 2025-06-30 | $8.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-28 | $9.24M derived: sum of 2 quarters · filed 2026-08-28 | $9.09M derived: sum of 3 quarters · filed 2026-08-28 | $8.93M 10-K · filed 2026-08-28 | |
| 2025-03-31 | $1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-12 | $911.00K derived: sum of 2 quarters · filed 2026-05-12 | $749.00K 10-Q · filed 2026-05-12 | $13.74M derived: sum of 4 quarters · filed 2026-05-12 | |
| 2024-12-31 | -$152.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2026-02-10 | -$314.00K 10-Q · filed 2026-02-10 | $12.68M derived: sum of 3 quarters · filed 2026-02-10 | $17.70M derived: sum of 4 quarters · filed 2026-02-10 | |
| 2024-09-30 | -$162.00K 10-Q/A · filed 2025-11-17 | $12.83M derived: sum of 2 quarters · filed 2025-11-17 | $17.86M derived: sum of 3 quarters · filed 2025-11-17 | $21.86M derived: sum of 4 quarters · filed 2025-11-17 | |
| 2024-06-30 | $12.99M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-05 | $18.02M derived: sum of 2 quarters · filed 2025-09-05 | $22.02M derived: sum of 3 quarters · filed 2025-09-05 | $24.49M 10-K · filed 2025-09-05 | |
| 2024-03-31 | $5.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-02 | $9.03M derived: sum of 2 quarters · filed 2025-05-02 | $11.50M 10-Q · filed 2025-05-02 | $14.24M derived: sum of 4 quarters · filed 2025-05-02 | |
| 2023-12-31 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-10 | $6.48M 10-Q · filed 2025-02-10 | $9.22M derived: sum of 3 quarters · filed 2025-02-10 | $10.68M derived: sum of 4 quarters · filed 2025-02-10 | |
| 2023-09-30 | $2.47M 10-Q · filed 2024-11-12 | $5.21M derived: sum of 2 quarters · filed 2024-11-12 | $6.68M derived: sum of 3 quarters · filed 2024-11-12 | $3.63M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $2.74M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-09-24 | $4.20M derived: sum of 2 quarters · filed 2024-09-24 | $1.16M derived: sum of 3 quarters · filed 2024-09-24 | $2.30M 10-K/A · filed 2024-09-24 | |
| 2023-03-31 | $1.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-13 | -$1.58M derived: sum of 2 quarters · filed 2024-05-13 | -$439.00K 10-Q · filed 2024-05-13 | -$449.00K derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | -$3.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-09 | -$1.90M 10-Q · filed 2024-02-09 | -$1.91M derived: sum of 3 quarters · filed 2024-02-09 | -$1.92M derived: sum of 4 quarters · filed 2024-02-09 | |
| 2022-09-30 | $1.14M 10-Q · filed 2023-11-14 | $1.13M derived: sum of 2 quarters · filed 2023-11-14 | $1.12M derived: sum of 3 quarters · filed 2023-11-14 | -$4.90M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-27 | -$20.00K derived: sum of 2 quarters · filed 2023-09-27 | -$6.04M derived: sum of 3 quarters · filed 2023-09-27 | -$6.13M 10-K · filed 2023-09-27 | |
| 2022-03-31 | -$10.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2023-05-15 | -$6.03M derived: sum of 2 quarters · filed 2023-05-19 | -$6.12M 10-Q · filed 2023-05-15 | -$3.20M derived: sum of 4 quarters · filed 2023-05-19 | |
| 2021-12-31 | -$6.02M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2023-05-19 | -$6.11M 10-Q/A · filed 2023-05-19 | -$3.19M derived: sum of 3 quarters · filed 2023-05-19 | $1.54M derived: sum of 4 quarters · filed 2023-05-19 | |
| 2021-09-30 | -$88.00K 10-Q · filed 2022-11-14 | $2.82M derived: sum of 2 quarters · filed 2022-11-14 | $7.56M derived: sum of 3 quarters · filed 2022-11-14 | $42.65M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $2.91M derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-11 | $7.65M derived: sum of 2 quarters · filed 2022-10-11 | $42.73M derived: sum of 3 quarters · filed 2022-10-11 | $78.83M 10-K · filed 2022-10-11 | |
| 2021-03-31 | $4.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-12 | $39.82M derived: sum of 2 quarters · filed 2022-05-12 | $75.92M 10-Q · filed 2022-05-12 | $125.68M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $35.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14 | $71.19M 10-Q · filed 2022-02-14 | $120.94M derived: sum of 3 quarters · filed 2022-02-14 | $131.23M derived: sum of 4 quarters · filed 2022-02-14 | |
| 2020-09-30 | $36.10M 10-Q · filed 2021-11-15 | $85.86M derived: sum of 2 quarters · filed 2021-11-15 | $96.15M derived: sum of 3 quarters · filed 2021-11-15 | $101.29M derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | $49.76M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | $60.05M derived: sum of 2 quarters · filed 2021-09-28 | $65.19M derived: sum of 3 quarters · filed 2021-09-28 | $65.19M 10-K · filed 2021-09-28 | |
| 2020-03-31 | $10.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-17 | $15.43M derived: sum of 2 quarters · filed 2021-05-17 | $15.43M 10-Q · filed 2021-05-17 | $15.38M derived: sum of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | $5.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-16 | $5.15M 10-Q · filed 2021-02-16 | $5.10M derived: sum of 3 quarters · filed 2021-02-16 | $5.05M derived: sum of 4 quarters · filed 2021-02-16 | |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-16 | -$50.00K derived: sum of 2 quarters · filed 2020-11-16 | -$100.00K derived: sum of 3 quarters · filed 2020-11-16 | $2.31M derived: sum of 4 quarters · filed 2020-11-16 | |
| 2019-06-30 | -$50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-13 | -$100.00K derived: sum of 2 quarters · filed 2020-10-13 | $2.31M derived: sum of 3 quarters · filed 2020-10-13 | $3.45M 10-K · filed 2020-10-13 | |
| 2019-03-31 | -$50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-15 | $2.36M derived: sum of 2 quarters · filed 2020-05-15 | $3.50M 10-Q · filed 2020-05-15 | $19.70M derived: sum of 4 quarters · filed 2020-05-15 | |
| 2018-12-31 | $2.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-14 | $3.55M 10-Q · filed 2020-02-14 | $19.75M derived: sum of 3 quarters · filed 2020-02-14 | $19.82M derived: sum of 4 quarters · filed 2020-02-14 | |
| 2018-09-30 | $1.14M 10-Q · filed 2019-11-14 | $17.34M derived: sum of 2 quarters · filed 2019-11-14 | $17.41M derived: sum of 3 quarters · filed 2019-11-14 | $22.59M derived: sum of 4 quarters · filed 2019-11-14 | |
| 2018-06-30 | $16.19M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-26 | $16.27M derived: sum of 2 quarters · filed 2019-08-26 | $21.45M derived: sum of 3 quarters · filed 2019-08-26 | $22.41M 10-K · filed 2019-08-26 | |
| 2018-03-31 | $75.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-10 | $5.26M derived: sum of 2 quarters · filed 2019-05-10 | $6.21M 10-Q · filed 2019-05-10 | $6.17M derived: sum of 4 quarters · filed 2019-05-10 | |
| 2017-12-31 | $5.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-13 | $6.14M 10-Q · filed 2019-02-13 | $6.09M derived: sum of 3 quarters · filed 2019-02-13 | $6.05M derived: sum of 4 quarters · filed 2019-02-13 | |
| 2017-09-30 | $956.00K 10-Q · filed 2018-11-13 | $912.00K derived: sum of 2 quarters · filed 2018-11-13 | $869.00K derived: sum of 3 quarters · filed 2018-11-13 | $827.00K derived: sum of 4 quarters · filed 2018-11-13 | |
| 2017-06-30 | -$44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-18 | -$87.00K derived: sum of 2 quarters · filed 2018-09-18 | -$129.00K derived: sum of 3 quarters · filed 2018-09-18 | -$170.00K 10-K · filed 2018-09-18 | |
| 2017-03-31 | -$43.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-11 | -$85.00K derived: sum of 2 quarters · filed 2018-05-11 | -$126.00K 10-Q · filed 2018-05-11 | ||
| 2016-12-31 | -$42.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-14 | -$83.00K 10-Q · filed 2018-02-14 | |||
| 2016-09-30 | -$41.00K 10-Q · filed 2017-11-09 | ||||
| 2013-06-30 | $3.83M 10-K/A · filed 2013-10-04 | ||||
| 2012-06-30 | $152.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-10-04 | $9.04M 10-K/A · filed 2013-10-04 | $9.04M 10-K/A · filed 2012-10-15 | ||
| 2012-03-31 | $9.04M 10-Q · filed 2013-05-20 | ||||
| 2011-06-30 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-10-15 | $7.37M 10-K/A · filed 2012-10-15 | |||
| 2011-03-31 | $7.37M 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |